Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

被引：64
作者：
Wang, Qi [1 ,2 ]
Chen, Zhi-Guo [1 ,2 ]
Du, Chang-Zheng [1 ,2 ]
Wang, Hong-Wei [1 ,2 ]
Yan, Li [3 ]
Gu, Jin [1 ,2 ]
机构：
[1] Peking Univ, Sch Oncol, Dept Colorectal Surg, Beijing Canc Hosp, Beijing 100871, Peoples R China
[2] Peking Univ, Sch Oncol, Beijing Canc Inst, Beijing 100871, Peoples R China
[3] Peking Univ, Sch Oncol, Beijing Canc Res Inst, Beijing 100871, Peoples R China
来源：
HISTOPATHOLOGY | 2009年 / 55卷 / 03期
关键词：
cancer stem cells; prognosis; rectal carcinoma; COLORECTAL-CANCER; PREOPERATIVE CHEMORADIATION; COLON-CANCER; EXPRESSION; IDENTIFICATION; RADIATION; SURVIVAL; DISEASE; CATENIN; LEVEL;
D O I：
10.1111/j.1365-2559.2009.03378.x
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Aims: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. According to the cancer stem cell hypothesis, CD133+ cells determine long-term tumour growth and are therefore suspected of influencing clinical outcome. The aim was to investigate the prognostic value of CD133 expression in rectal cancer patients after preoperative radiation and curative resection. Methods and results: The expression of the CD133 stem cell antigen in a series of 73 patients with rectal cancer of various ypTNM stages was analysed by immunohistochemistry on formalin-fixed paraffin-embedded sections. The prognostic value of CD133 expression and other clinicopathological factors was evaluated. On multivariate survival analysis, the proportion of CD133+ cells was a significant (P < 0.05) prognostic factor for adverse disease-free survival and overall survival independent of ypTNM stage, tumour differentiation or lymphovascular invasion. Conclusions: CD133 stem cell antigen expression correlates with patient survival in rectal cancer, lending support to the current cancer stem cell hypothesis.
引用
收藏
页码：284 / 293
页数：10
相关论文
共 31 条
[1]   Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study [J].
Allegra, CJ ;
Paik, S ;
Colangelo, LH ;
Parr, AL ;
Kirsch, I ;
Kim, G ;
Klein, P ;
Johnston, PG ;
Wolmark, N ;
Wieand, HS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :241-250
[2]  
AMY HY, 1997, BLOOD, V90, P5002
[3]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[4]   Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: A population-based analysis [J].
Baxter, NN ;
Morris, AM ;
Rothenberger, DA ;
Tepper, JE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :426-431
[5]  
CAROLYN C, 2004, CA-CANCER J CLIN, V54, P295
[6]  
CLAUS R, 2005, J CLIN ONCOL, V23, P8688
[7]   Prospective identification of tumorigenic prostate cancer stem cells [J].
Collins, AT ;
Berry, PA ;
Hyde, C ;
Stower, MJ ;
Maitland, NJ .
CANCER RESEARCH, 2005, 65 (23) :10946-10951
[8]   Tumor markers and colorectal cancer: Utility in management [J].
Crawford, NPS ;
Colliver, DW ;
Galandiuk, S .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (04) :239-248
[9]   LEVEL OF EXPRESSION OF E-CADHERIN MESSENGER-RNA IN COLORECTAL-CANCER CORRELATES WITH CLINICAL OUTCOME [J].
DORUDI, S ;
HANBY, AM ;
POULSOM, R ;
NORTHOVER, J ;
HART, IR .
BRITISH JOURNAL OF CANCER, 1995, 71 (03) :614-616
[10]  
ELLEN KCA, 2001, NEW ENGL J MED, V345, P638
1234